- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07605754
Results of Nerve Surgery to Treat PostAmputation Pain (TreatPAP)
Results of Nerve Surgery to Treat PostAmputation Pain (TreatPAP): a Prospective Study
Rationale: Postamputation pain (PAP) is frequently seen after amputations and is a severe lifelong disabling condition affecting quality of life (QoL). Different nerve surgical techniques are available to treat PAP if non-surgical treatment options are not sufficient. Multiple techniques have been described for treatment of symptomatic neuromas with varying results. Techniques described include traction neurectomy with/without implantation, nerve grafting, nerve capping, regenerative peripheral nerve interface, and targeted muscle reinnervation (TMR). In the Leiden University Medical Center (LUMC), the most common techniques to treat painful neuromas include TMR and fascicular split (FS). TMR involves coaptating the transected mixed nerve to functional motor nerves, showing promising results in recent studies. FS is a technique closely related to neurectomy with implantation in a functional muscle. The difference is that with FS, the nerve is split into fascicles before implantation to allow for better distribution of nerve fibers. These techniques have not yet been compared. In this study, the investigators will compare both these techniques in a prospective setting for the treatment of PAP. The hypothesis is, that after 12 months, pain will be diminished and QoL will be increased in all patients versus the pre-operative status. There will be little to no difference in outcome between the surgical techniques used.
Objective: To evaluate limb pain in patients with intractable postamputation pain (residual limb pain and phantom limb pain) one year after nerve embedding surgery following the standardized workup of the LUMC.
Study design: Prospective study Study population: Patients 18 years of age or older, with a history of more than 6 months of intractable postamputation neuropathic limb pain, with no history of previous surgical intervention for pain treatment, referred to the Leiden Nerve Center.
Main study parameters/endpoints: The mean difference in pain scores for phantom limb pain and residual limb pain one year postoperatively. An average pain score from the past 7 days is used for PLP and RLP individually, on the 11-point (0-10) numerical rating scale (NRS). Additionally, the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Behavior and Interference Questionnaire Short Forms (7a and 8a, respectively) are used one year postoperatively.
Nature and extent of the burden and risks associated with participation, benefit, and group relatedness: Both techniques are currently used in the Leiden University Medical Center (LUMC) and considered standard of care. The decision to perform either technique is solely dependent on the personal preference of the treating nerve surgeon. The results of this trial will improve the understanding of the treatment effect of both surgical techniques with a minimal patient burden. Participation requires patients to complete 3-4 non-invasive questionnaires about pain, quality of life, depression and anxiety, and mobility over a period of 2 years. The pre-operative (if applicable) and 12-month postoperative questionnaire will each take approximately 15 minutes to complete. The other two questionnaires at 18 and 24 months postoperative will take approximately 3-4 minutes to complete. Additionally, participants will fill out a daily questionnaire consisting of one to three questions about pain for 7 consecutive days at 12 months.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Postamputation pain (PAP) is a common sequela after major lower limb amputation, with an estimated incidence of 61%. PAP can be divided into two major categories: phantom limb pain (PLP) and residual limb pain (RLP, 'stump pain'). Both RLP and PLP are predominantly driven by the cut nerve endings during the amputation, that form terminal-neuromas. PAP is known to compromise prosthetic rehabilitation and profoundly diminishes the quality of life after amputation. When PAP develops, it is extremely difficult to treat. When non-surgical treatment fails, or side effects of medication dominate patients' lives, surgery for PAP is occasionally undertaken. Nerve surgical techniques that are then applied differ widely and lack any solid scientific base. In general, secondary surgery for PAP includes resection of the neuroma and transposition of the freshened nerve into a more favorable environment, such as muscle, bone, vessels, or fat. This nerve implantation technique has been described since 1918 to treat painful neuromas, showing good results ranging from 64 to 82% of pain relief. Based on the vast experience gained over a 25-year period in the Leiden Nerve Center in treating painful neuromas, an adaptation of the nerve implantation method was developed called the Fascicular Split (FS) technique to treat PAP. In the FS technique, after transecting the neuroma, the nerve is first split into multiple fascicles before implanting the nerve in the muscle. This allows for better distribution of the nerve in the muscle, resulting in less neuroma formation. The strength of FS is its relative simplicity, which is crucial for the wider implementation in routine care. Promising results were observed applying this technique in a small series (n=8) of patients with PAP yielding a long-lasting, life-changing effect in all but one patient. In some cases, FS was performed years after the initial amputation and after previous failed neuroma surgeries. Other nerve handling techniques to treat symptomatic neuroma include centro-central neurorrhaphy, End-to-Side neurorrhaphy, Graft to Nowhere, Targeted Muscle Reinnervation (TMR), and Regenerative Peripheral Nerve Interface. TMR is, after simply embedding the nerve in healthy tissue, the best studied and most promising technique to treat PAP. Several cohort studies and a recent randomized trial in secondary surgery for PAP show that a nerve surgical technique called Targeted Muscle Reinnervation (TMR) is effective in treating PAP. However, the main disadvantage of TMR is that it is a time-consuming procedure.
To date, there are no studies that compare both techniques for the treatment of PAP. The investigators believe that the treatment FS yields similar results to TMR. Moreover, in terms of clinical applicability, the FS technique is easier to learn, does not require extensive nerve surgical skills, and does not take much time to perform.
Few papers have been published on TMR as a treatment for postamputation pain. Despite issues with the validity of the articles, results of PLP and RLP were consistently in favor of TMR as a technique regarding all outcome measures, including intensity and interference with daily activities. FS, although not mentioned in the literature, has many similarities with nerve implantation, which showed similarly good results for the treatment of painful neuromas. However, there have been no studies to date that directly compare the two techniques.
PAP is a lifelong disabling condition profoundly affecting quality of life. Nerve embedding surgical techniques (simple, FS, and TMR) have proven to be effective to treat postamputation pain. Preliminary results show that simple embedding, TMR, and FS are potentially good techniques to treat invalidating PAP. However, no comparative studies have been performed.
The investigators hypothesize that FS will show equally good results compared to TMR in the surgical treatment of intractable PAP, reducing pain, and improving quality-of-life (QoL) and mobility.
The investigators propose a prospective observational cohort study evaluating outcomes after various nerve embedding techniques following a standardized selection protocol in patients with intractable post-amputation pain after a major limb amputation.
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Guus A.H. Tendijck, MD
- Numero di telefono: +316 21320645
- Email: g.tendijck@hotmail.com
Luoghi di studio
-
-
South Holland
-
Leiden, South Holland, Olanda, 2333 ZA
- Reclutamento
- Leiden University Medical Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Age older than or equal to 18 years
- Intractable postamputation pain
Exclusion Criteria:
- Cognitive impairment or delirium at the time of inclusion
- Having received previous radiotherapy on the affected limb
- Patients who are unable to comprehend the informed consent form or the questionnaires used in the current study
- Unfit for general anesthesia
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Control: Targeted Muscle Reinnervation (TMR)
Patients with a symptomatic neuroma requiring surgical intervention
|
Targeted Muscle Reinnervation surgical technique
|
|
Intervention: Fascicular split
Patients with a symptomatic neuroma requiring surgical intervention
|
Fasicular split surgical technique:
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Phantom limb pain measured on the 11-point (0-10) numeric rating scale.
Lasso di tempo: 1 year postoperatively
|
A primary endpoint is the mean phantom limb pain experience one year postoperatively.
This will be measured on the 11-point (0-10) numeric rating scale over 7 consecutive days.
A higher score indicates worse pain.
|
1 year postoperatively
|
|
Residual limb pain measured on the 11-point numeric rating scale
Lasso di tempo: 1 year postoperatively
|
A primary endpoint is the mean residual limb pain experience one year postoperatively.
This will be measured on the 11-point (0-10) numeric rating scale over 7 consecutive days.
A higher score indicates worse pain.
|
1 year postoperatively
|
|
PROMIS pain behavior short form 7a
Lasso di tempo: 1 year postoperatively
|
PROMIS pain behavior short form 7a in Dutch-Flemish
|
1 year postoperatively
|
|
PROMIS pain interference short form 8a
Lasso di tempo: 1 year postoperatively
|
PROMIS pain interference short form 8a in Dutch-Flemish
|
1 year postoperatively
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Phantom limb pain using the 11-point (0-10) numeric rating scale
Lasso di tempo: From enrolment until 24 months post-operatively
|
From enrolment until 24 months post-operatively
|
|
|
Residual limb pain using the 11-point (0-10) numeric rating scale
Lasso di tempo: From enrolment until 24 months postoperatively
|
From enrolment until 24 months postoperatively
|
|
|
PROMIS pain behavior 7a short form in Dutch-Flemish
Lasso di tempo: From enrolment until 24 months postoperatively
|
From enrolment until 24 months postoperatively
|
|
|
PROMIS pain interference 8a short form in Dutch-Flemish
Lasso di tempo: From enrolment until 24 months postoperatively
|
From enrolment until 24 months postoperatively
|
|
|
Quality of life (EQ-5D-5L)
Lasso di tempo: From enrolment until 24 months postoperatively
|
From enrolment until 24 months postoperatively
|
|
|
Pain type using the ICAN localization map
Lasso di tempo: From enrolment until 12 months postoperatively
|
From enrolment until 12 months postoperatively
|
|
|
Neuropathic pain using the PainDetect
Lasso di tempo: From enrolment until 12 months postoperatively
|
From enrolment until 12 months postoperatively
|
|
|
Hospital anxiety and depression using the HADS
Lasso di tempo: From enrolment until 12 months postoperatively
|
From enrolment until 12 months postoperatively
|
|
|
Perceived treatment effect using the GPE-DV
Lasso di tempo: at 12 months postoperativley
|
at 12 months postoperativley
|
|
|
Prosthetic rehabilitation using the PLUS-M
Lasso di tempo: From enrolment until 12 months postoperatively
|
From enrolment until 12 months postoperatively
|
|
|
Changes in sensory quality in the amputated stump using quantitative sensory testing (QST)
Lasso di tempo: at enrolment until 12 months postoperative
|
at enrolment until 12 months postoperative
|
|
|
Quantified neuroma perfusion using near-infrared fluorescence using indocyanine green
Lasso di tempo: Peri-operatively
|
Patients will receive near-infrared (NIR) fluorescence imaging with indocyanine green (ICG) during the surgery.
ICG is a fluorescent dye that binds to plasma proteins and emits light when excited by near-infrared wavelengths.
After intravenous injection, the dye circulates rapidly, allowing surgeons to assess blood flow to tissue of interest.
This method has very good safety profile and has been used extensively in gastro-intestinal, reconstructive, vascular and neurosurgery.
This study aims to use quantified ICG NIR fluorescence imaging to evaluate perfusion patterns of symptomatic and asymptomatic neuromas after amputation.
|
Peri-operatively
|
|
Surgery duration
Lasso di tempo: Perioperatively
|
in minutes
|
Perioperatively
|
|
Length of hospital stay
Lasso di tempo: From the date of surgery to the date of discharge from the hospital, up to 1 year post surgery
|
Amount of days patients spent in hospital post surgery
|
From the date of surgery to the date of discharge from the hospital, up to 1 year post surgery
|
|
Adverse events
Lasso di tempo: until 30 days postoperatively
|
i.e., infection, rebleed, with Clavien-Dindo scores
|
until 30 days postoperatively
|
|
Medication Quantification Scale
Lasso di tempo: until 24 months postoperatively
|
Phantom limb pain, residual limb pain, the PROMIS pain behavior 7a short form, and the PROMIS interference 8a short form will be corrected for pain medication use, using the medication quantification scale.
A higher score indicates more pain medication use.
|
until 24 months postoperatively
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Justus L. Groen, MD, PhD, Leiden University Medical Center
Pubblicazioni e link utili
Pubblicazioni generali
- Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
- Terwee CB, Roorda LD, de Vet HC, Dekker J, Westhovens R, van Leeuwen J, Cella D, Correia H, Arnold B, Perez B, Boers M. Dutch-Flemish translation of 17 item banks from the patient-reported outcomes measurement information system (PROMIS). Qual Life Res. 2014 Aug;23(6):1733-41. doi: 10.1007/s11136-013-0611-6. Epub 2014 Jan 9.
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
- Harden RN, Weinland SR, Remble TA, Houle TT, Colio S, Steedman S, Kee WG; American Pain Society Physicians. Medication Quantification Scale Version III: update in medication classes and revised detriment weights by survey of American Pain Society Physicians. J Pain. 2005 Jun;6(6):364-71. doi: 10.1016/j.jpain.2005.01.350.
- Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001 Nov;94(2):149-158. doi: 10.1016/S0304-3959(01)00349-9.
- Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006 Oct;22(10):1911-20. doi: 10.1185/030079906X132488.
- Dumanian GA, Potter BK, Mioton LM, Ko JH, Cheesborough JE, Souza JM, Ertl WJ, Tintle SM, Nanos GP, Valerio IL, Kuiken TA, Apkarian AV, Porter K, Jordan SW. Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized Clinical Trial. Ann Surg. 2019 Aug;270(2):238-246. doi: 10.1097/SLA.0000000000003088.
- Hudak PL, Wright JG. The characteristics of patient satisfaction measures. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3167-77. doi: 10.1097/00007632-200012150-00012.
- Mioton LM, Dumanian GA, Shah N, Qiu CS, Ertl WJ, Potter BK, Souza JM, Valerio IL, Ko JH, Jordan SW. Targeted Muscle Reinnervation Improves Residual Limb Pain, Phantom Limb Pain, and Limb Function: A Prospective Study of 33 Major Limb Amputees. Clin Orthop Relat Res. 2020 Sep;478(9):2161-2167. doi: 10.1097/CORR.0000000000001323.
- Schwingler PM, Moman RN, Hunt C, Ashmore Z, Ogletree SP, Uvodich ME, Murad MH, Hooten WM. Prevalence of postamputation pain and its subtypes: a meta-analysis with meta-regression. Pain Rep. 2021 May 4;6(1):e918. doi: 10.1097/PR9.0000000000000918. eCollection 2021.
- Poyntz SA, Hacking NM, Dalal M, Fowler S. Peripheral Interventions for Painful Stump Neuromas of the Lower Limb: A Systematic Review. Clin J Pain. 2018 Mar;34(3):285-295. doi: 10.1097/AJP.0000000000000533.
- Berger LE, Shin S, Haffner ZK, Huffman SS, Spoer DL, Sayyed AA, Franzoni G, Bekeny JC, Attinger CE, Kleiber GM. The application of targeted muscle reinnervation in lower extremity amputations: A systematic review. Microsurgery. 2023 Oct;43(7):736-747. doi: 10.1002/micr.31030. Epub 2023 Mar 2.
- Ives GC, Kung TA, Nghiem BT, Ursu DC, Brown DL, Cederna PS, Kemp SWP. Current State of the Surgical Treatment of Terminal Neuromas. Neurosurgery. 2018 Sep 1;83(3):354-364. doi: 10.1093/neuros/nyx500.
- Dellon AL, Mackinnon SE. Treatment of the painful neuroma by neuroma resection and muscle implantation. Plast Reconstr Surg. 1986 Mar;77(3):427-38. doi: 10.1097/00006534-198603000-00016.
- O'Brien AL, Jordan SW, West JM, Mioton LM, Dumanian GA, Valerio IL. Targeted Muscle Reinnervation at the Time of Upper-Extremity Amputation for the Treatment of Pain Severity and Symptoms. J Hand Surg Am. 2021 Jan;46(1):72.e1-72.e10. doi: 10.1016/j.jhsa.2020.08.014. Epub 2020 Oct 22.
- Kang NV, Woollard A, Michno DA, Al-Ajam Y, Tan J, Hansen E. A consecutive series of targeted muscle reinnervation (TMR) cases for relief of neuroma and phantom limb pain: UK perspective. J Plast Reconstr Aesthet Surg. 2022 Mar;75(3):960-969. doi: 10.1016/j.bjps.2021.09.068. Epub 2021 Oct 22.
- Anné C, de Laat FA, Hafner BJ, et al. "Dutch-Flemish translation of the Prosthetic Limb Users Survey of Mobility (PLUS-M)". Poster tijdens het PROMIS congres Praag. 2022.
- Gomez-Eslava B, Raasveld FV, Hoftiezer YAJ, McCarty JC, Daddario JL, Valerio IL, Heng M, Eberlin KR. Pain Sketches to Predict Pain following Primary Targeted Muscle Reinnervation in Amputees. Plast Reconstr Surg. 2024 May 1;153(5):1162-1171. doi: 10.1097/PRS.0000000000010762. Epub 2023 May 26.
- Schafer B, Freund G, Orr J, Nolte K, Weis J, Bahm J, Beier JP. Technique and Expected Benefit of Intraoperative Perfusion Imaging of Peripheral Nerves. Plast Reconstr Surg Glob Open. 2024 Nov 5;12(11):e6281. doi: 10.1097/GOX.0000000000006281. eCollection 2024 Nov.
- Nederlandse Vereniging van Revalidatieartsen. Amputatie en prothesiologie onderste extremiteit. Available from: https://richtlijnendatabase.nl/richtlijn/amputatie_prothesiologie_onderste_extremiteit/startpagina_-_amputatie_en_prothesiologie_onderste_extremiteit.html.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 25-3058
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Targeted Muscle Reinnervation
-
Second Affiliated Hospital, School of Medicine,...Non ancora reclutamentoTerapia cellulare | Cardiomiopatia ischemica
-
Endourage, LLCCompletatoLungo COVID | Lungo Covid19 | Post-acuto COVID-19 | Lungo raggio COVID | COVID-19 a lungo raggio | Sindrome post-acuta da COVID-19Stati Uniti
-
Endourage, LLCCompletato
-
University Health Network, TorontoReclutamento
-
Baystate Medical CenterTerminatoSindrome da distress respiratorio, neonato | Prematurità | BPD - Displasia broncopolmonareStati Uniti
-
Mayo ClinicNational Cancer Institute (NCI)ReclutamentoMieloma multiplo refrattario | Mieloma multiplo ricorrenteStati Uniti